Determined that patients with diffuselarge B celllymphoma had high serum levels of miR-21, which associated with increased relapse-free survival 3. Around the same time, Mitchell et al.
Objective to observe the effect and toxicity of rituximab and CHOP regimen (R-CHOP) in the treatment of initially diagnosed diffuselarge B-celllymphoma.